Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease

被引:77
|
作者
Shukla, Pradeep K. [1 ]
Delotterie, David F. [2 ]
Xiao, Jianfeng [2 ]
Pierre, Joseph F. [3 ]
Rao, RadhaKrishna [1 ]
McDonald, Michael P. [2 ,4 ,5 ]
Khan, Mohammad Moshahid [2 ,5 ,6 ,7 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Coll Med, Memphis, TN 38163 USA
[2] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Neurol, Memphis, TN 38163 USA
[3] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pediat, Memphis, TN 38163 USA
[4] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Anat & Neurobiol, Memphis, TN 38163 USA
[5] Univ Tennessee, Hlth Sci Ctr, Neurosci Inst, Memphis, TN 38163 USA
[6] Univ Tennessee, Hlth Sci Ctr, Ctr Muscle Metab & Neuropathol, Div Rehabil Sci, Memphis, TN 38163 USA
[7] Univ Tennessee, Hlth Sci Ctr, Dept Phys Therapy, Coll Hlth Profess, Memphis, TN 38163 USA
关键词
alzheimer’ s disease; gut microbiota; NLRP3; inflammasome; amyloid-beta; neuroinflammation;
D O I
10.3390/cells10040779
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population. Despite decades of scientific research, the underlying etiological triggers are unknown. Recent studies suggested that gut microbiota can influence AD progression; however, potential mechanisms linking the gut microbiota with AD pathogenesis remain obscure. In the present study, we provided a potential mechanistic link between dysbiotic gut microbiota and neuroinflammation associated with AD progression. Using a mouse model of AD, we discovered that unfavorable gut microbiota are correlated with abnormally elevated expression of gut NLRP3 and lead to peripheral inflammasome activation, which in turn exacerbates AD-associated neuroinflammation. To this end, we observe significantly altered gut microbiota compositions in young and old 5xFAD mice compared to age-matched non-transgenic mice. Moreover, 5xFAD mice demonstrated compromised gut barrier function as evident from the loss of tight junction and adherens junction proteins compared to non-transgenic mice. Concurrently, we observed increased expression of NLRP3 inflammasome and IL-1 beta production in the 5xFAD gut. Consistent with our hypothesis, increased gut-microbial-inflammasome activation is positively correlated with enhanced astrogliosis and microglial activation, along with higher expression of NLRP3 inflammasome and IL-1 beta production in the brains of 5xFAD mice. These data indicate that the elevated expression of gut-microbial-inflammasome components may be an important trigger for subsequent downstream activation of inflammatory and potentially cytotoxic mediators, and gastrointestinal NLRP3 may promote NLRP3 inflammasome-mediated neuroinflammation. Thus, modulation of the gut microbiota may be a potential strategy for the treatment of AD-related neurological disorders in genetically susceptible hosts.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur, Ashwinipriyadarshini
    Baltriukiene, Daiva
    Bukelskiene, Virginija
    Burokas, Aurelijus
    NUTRIENTS, 2021, 13 (01) : 1 - 24
  • [22] The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer's Disease
    Narengaowa
    Kong, Wei
    Lan, Fei
    Awan, Umer Farooq
    Qing, Hong
    Ni, Junjun
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [23] The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease
    Wiatrak, Benita
    Balon, Katarzyna
    Jawien, Paulina
    Bednarz, Dominika
    Jeskowiak, Izabela
    Szelag, Adam
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [24] The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology
    Doifode, Tejaswini
    Giridharan, Vijayasree V.
    Generoso, Jaqueline S.
    Bhatti, Gursimrat
    Collodel, Allan
    Schulz, Paul E.
    Forlenza, Orestes, V
    Barichello, Tatiana
    PHARMACOLOGICAL RESEARCH, 2021, 164
  • [25] Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease
    Escobar, Yael-Natalie H.
    O'Piela, Devin
    Wold, Loren E.
    Mackos, Amy R.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (01) : 17 - 31
  • [26] Gut-brain axis and Alzheimer's disease: Therapeutic interventions and strategies
    Singh, Hetender
    Chopra, Chirag
    Singh, Hemender
    Malgotra, Vikas
    Wani, Atif Khurshid
    Dhanjal, Daljeet Singh
    Sharma, Indu
    Nepovimova, Eugenie
    Alomar, Suliman
    Singh, Reena
    Sharma, Varun
    Kuca, Kamil
    JOURNAL OF FUNCTIONAL FOODS, 2024, 112
  • [27] Gut microbiota-driven metabolic alterations reveal gut-brain communication in Alzheimer's disease model mice
    Chen, Yijing
    Li, Yinhu
    Fan, Yingying
    Chen, Shuai
    Chen, Li
    Chen, Yuewen
    Chen, Yu
    GUT MICROBES, 2024, 16 (01)
  • [28] Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease
    Syeda, Tauqeerunnisa
    Sanchez-Tapia, Monica
    Pinedo-Vargas, Laura
    Granados, Omar
    Cuervo-Zanatta, Daniel
    Rojas-Santiago, Eleazar
    Diaz-Cintra, Sofia
    Torres, Nimbe
    Perez-Cruz, Claudia
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (04) : 1657 - 1682
  • [29] Alterations in the Gut Fungal Community in a Mouse Model of Huntington's Disease
    Kong, Geraldine
    Cao, Kim-Anh Le
    Hannan, Anthony J.
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [30] Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer's Disease
    Yu, Ting
    Xing, Yueyang
    Gao, Qi
    Wang, Dandan
    Chen, Hongzhuan
    Wang, Hao
    Zhang, Yongfang
    Bauer, Bjoern
    PHARMACEUTICS, 2023, 15 (12)